Please select 'Verify My Prescriber(s)' below to initiate the verification process for all registered prescribers. To minimize interruption to your workflow, please be sure all prescribers are verified.
Asembia Privacy Policy
Asembia shares a commitment with the prescribers utilizing Triluron® ER website, who are HIPAA covered entities (collectively "Covered Entities"), to protect the privacy and confidentiality of Protected Health Information (PHI) in accordance with applicable HIPAA regulations. Asembia is also committed to protecting Personally Identifiable Information (PII) submitted by users of the Triluron website. This Policy is provided by Asembia to help you better understand how we disclose and protect PHI in accordance with the terms of the Business Associate (BA) Agreement and how we protect and use PII. PLEASE NOTE, YOUR USE AND CONTINUED USE OF THE Triluron WEBSITE CONSTITUTES YOUR UNDERSTANDING AND AGREEMENT WITH THIS PRIVACY POLICY.
SafeguardsAsembia's policy is to maintain the confidentiality of PHI received from or on behalf of clients who are HIPAA Covered Entities and with whom we have executed a BA Agreement in accordance with such Agreements and applicable law. Asembia has implemented appropriate administrative, technical and physical safeguards for protecting the privacy of PHI and PII.
Use and Disclosure of DataWe may use PII and PHI for our management, administration, data aggregation and legal obligations to the extent such use of PII and PHI is permitted or required by the BA Agreement and this Privacy Policy and would not violate HIPAA regulations. We may also share de-identified data and select PII with business partners or potential business partners. No PHI information is shared with business partners or potential business partners, except as otherwise permitted by applicable law and the BA Agreement. In the event that PII and PHI must be disclosed to a subcontractor or agent, we will ensure that the subcontractor or agent agrees to abide by the same restrictions and conditions that apply to us under the BA Agreement and this Privacy Policy with respect to PII and PHI, including the implementation of reasonable and appropriate safeguards. We may also use PII and PHI to report violations of law to appropriate federal and state authorities, as permitted by the BA Agreement and applicable law.
Indication
TRILURON® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g. acetaminophen).
Important Safety Information
Do not administer TRILURON® to patients with known hypersensitivity to hyaluronate preparations. Intra-articular injections are contraindicated in cases of past and present infections or skin diseases in the area of the injection site to reduce the potential for developing septic arthritis. The safety and effectiveness of TRILURON® has not been tested in pregnant women, nursing mothers or children. See package insert for full prescribing information including adverse events, warnings, precautions, and side effects at www.TRILURON.com.
We could not match a prescriber with the information provided. Please select ‘OK’ to review your entry and try again.
For additional support please contact 866-749-2542
One or more of the authentication questions were answered incorrectly.
The Prescriber has been found; checking status now.
You have not successfully completed the authentication process
For additional support please contact 866-749-2542.
Congratulations! You have successfully completed the verification process.
The prescriber will be validated until 4/25/2025 7:24:10 PM